Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 16;113(8):1190-1205.e9.
doi: 10.1016/j.neuron.2025.02.005. Epub 2025 Mar 11.

PTPσ-mediated PI3P regulation modulates neurodegeneration in C9ORF72-ALS/FTD

Affiliations

PTPσ-mediated PI3P regulation modulates neurodegeneration in C9ORF72-ALS/FTD

Zhe Zhang et al. Neuron. .

Abstract

The most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is the repeat expansion in C9ORF72. Dipeptide repeat (DPR) proteins translated from both sense and antisense repeats, especially arginine-rich DPRs (R-DPRs), contribute to neurodegeneration. Through CRISPR interference (CRISPRi) screening in human-derived neurons, we identified receptor-type tyrosine-protein phosphatase S (PTPσ) as a strong modifier of poly-GR-mediated toxicity. We showed that reducing PTPσ promotes the survival of both poly-GR- and poly-PR-expressing neurons by elevating phosphatidylinositol 3-phosphate (PI3P), accompanied by restored early endosomes and lysosomes. Remarkably, PTPσ knockdown or inhibition substantially rescues the PI3P-endolysosomal defects and improves the survival of C9ORF72-ALS/FTD patient-derived neurons. Furthermore, the PTPσ inhibitor diminishes GR toxicity and rescues pathological and behavioral phenotypes in mice. Overall, these findings emphasize the critical role of PI3P-mediated endolysosomal deficits induced by R-DPRs in disease pathogenesis and reveal the therapeutic potential of targeting PTPσ in C9ORF72-ALS/FTD.

Keywords: ALS; C9ORF72; CRISPR screening; FTD; PI3P; PTPσ; endosome; lysosome; poly-GR/PR.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests S.S. and Z.Z. are inventors on a patent application (PCT/US2024/027681) related to research presented in this study.

References

    1. Boillée S, Vande Velde C, and Cleveland DW (2006). ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52, 39–59. 10.1016/j.neuron.2006.09.018. - DOI - PubMed
    1. Bang J, Spina S, and Miller BL (2015). Frontotemporal dementia. Lancet 386, 1672–1682. 10.1016/S0140-6736(15)00461-4. - DOI - PMC - PubMed
    1. Ling SC, Polymenidou M, and Cleveland DW (2013). Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79, 416–438. 10.1016/j.neuron.2013.07.033. - DOI - PMC - PubMed
    1. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, et al. (2011). Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72, 245–256. 10.1016/j.neuron.2011.09.011. - DOI - PMC - PubMed
    1. Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, et al. (2011). A Hexanucleotide Repeat Expansion in Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron 72, 257–268. 10.1016/j.neuron.2011.09.010. - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources